No to Acta, yes to the right to health

The United Nations Special Rapporteur on the right to health, Anand Grover, praised the European Parliament’s rejection of the Anti-Counterfeiting Trade Agreement (ACTA) on July 4 as a step in the right direction to ensure continued access to affordable and essential drugs and medication essential for the fulfillment of the right to health

Photo: No to Acta, yes to the right to health
Photo: No to Acta, yes to the right to health

According to Grover, ACTA’s defeat in Europe was a welcome blow to the flawed agreement which had failed to address numerous concerns related to access to medicines. In July 2011, the UN Human Rights Council requested the Special Rapporteur to study existing challenges with regard to access to medicines, ways to overcome them and good practices. He will present the study to the Council in June 2013


More on the subject:
Read all latest stories

Related articles


Experts express concerns

EDQM Blood Guide could make Europe more dependent on US plasma

The Plasma Protein Therapeutics Association (PPTA) is concerned about the recommendations contained in 20th version of Blood Guide of The European Directorate for the Quality of Medicines (EDQM)…


Medical Device Regulation

How the new MDR may hurt patients in the short term

The intentions behind the Medical Device Regulation (MDR) are good. Ultimately, the regulations should prevent inferior medical devices, technologies and pharmaceuticals from endangering peoples’…


Dutch experts discuss

On the implications of the coronavirus

The coronavirus last week reached the Netherlands and began to spread around the country. How has the Dutch population reacted? What is a useful frame of reference for this situation? And what are…